← Leaderboards
James G. Kublin
University Of Maryland Baltimore
$4,465,506
Attributed
$4,540,505
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $923.1K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,540,505 · 4
By mechanism
R01$3,631,665 · 1
R13$674,991 · 1
D43$131,287 · 1
K01$102,562 · 1
Top collaborators
- Alison Christina Roxby2 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Harry L. Mobley$24,735,775
- Christopher V. Plowe$27,953,996
- Miriam K Laufer$32,646,632
- Edgar C. Boedeker$2,420,476
- Wilbur H. Chen$12,119,388
Others in their field
Top investigators on “Hiv Vaccine”
- Lawrence Corey · Fred Hutchinson Cancer Center$780,408,880
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$575,377,030
- Barton F Haynes · Duke University$498,748,538
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,795,024
- Dennis R. Burton · Scripps Research Institute$316,405,695
- Myron S Cohen · Family Health International$228,494,927
Research focus
Hiv VaccineLearningVaccinesComorbidityClinical TrialsPandemic DiseaseNeeds AssessmentPeerCareerMeetingsEvaluationFundingClinical ResearchNonhuman PrimateMentorsCollaborationsHiv Vaccine Trials NetworkHiv InfectionsEpidemicGroup MeetingsInnovationDisabled PersonsCareer DevelopmentPre-Clinical
Grant awards (17)
Annual HVTN Translational HIV Early Stage Investigator (ESI) Conference$74,999
R13 · FY2025 · OD · contact PI
Annual HVTN Translational HIV Early Stage Investigator (ESI) Conference$74,999
R13 · FY2024 · OD · contact PI
Annual HVTN Translational HIV Early Stage Investigator (ESI) Conference$74,999
R13 · FY2023 · OD · contact PI
Annual HVTN Translational HIV Early Stage Investigator (ESI) Conference$74,999
R13 · FY2022 · OD · contact PI
Annual HVTN Translational HIV Early Stage Investigator (ESI) Conference$74,999
R13 · FY2021 · OD · contact PI
Role of the microbiome in HIV vaccine induced heterogeneity$504,977
R01 · FY2020 · AI · contact PI
Annual HVTN Translational HIV Early Stage Investigator (ESI) Conference$74,999
R13 · FY2020 · OD · contact PI
Role of the microbiome in HIV vaccine induced heterogeneity$739,661
R01 · FY2019 · AI · contact PI
Annual Conference For Early Stage HIV/AIDS Vaccine Researchers$74,999
R13 · FY2019 · OD · contact PI
Role of the microbiome in HIV vaccine induced heterogeneity$848,148
R01 · FY2018 · AI · contact PI
Annual Conference For Early Stage HIV/AIDS Vaccine Researchers$74,999
R13 · FY2018 · OD · contact PI
Role of the microbiome in HIV vaccine induced heterogeneity$772,302
R01 · FY2017 · AI · contact PI
Annual Conference For Early Stage HIV/AIDS Vaccine Researchers$74,999
R13 · FY2017 · OD · contact PI
Role of the microbiome in HIV vaccine induced heterogeneity$766,577
R01 · FY2016 · AI · contact PI
Malaria at the Mother-child Interface$131,287
D43 · FY2013 · TW · contact PI
IMPACT OF TS PROPHYLAXIS ON ANTIFOLATE RESISTANT MALARIA$75,562
K01 · FY2000 · TW
IMPACT OF TS PROPHYLAXIS ON ANTIFOLATE RESISTANT MALARIA$27,000
K01 · FY2000 · TW